The US FDA has approved Vtama 1% cream for the topical treatment of atopic dermatitis in adult and pediatric patients aged 2 ...

The FDA has approved Organon’s Vtama (tapinarof) cream, 1%, for the treatment of atopic dermatitis (AD) in adults and children as young as two years of age. According to the company, the approval was ...

“With the FDA’s approval of VTAMA cream in atopic dermatitis for adults and children ... You are encouraged to report negative side effects of prescription drugs to the FDA.

The FDA approved tapinarof cream 1% (VTAMA; Organon) today to treat patients aged 2 and older with atopic dermatitis. Ahead of its extended target action date of March 12, 2025, the FDA approved ...

Opens in a new tab or window Tapinarof 1% topical cream showed greater efficacy than the control in adults and children as young as age 2 years with atopic dermatitis (AD). The cream also provided ...

More patients treated with Vtama achieved vIGA-AD success compared with those who received vehicle cream in both ADORING 1 (45% vs 14%) and ADORING 2 (46% vs 18%). The Food and Drug Administration ...

The FDA has blessed two previously approved medicines—one a cream and the other an injection—to treat atopic dermatitis (AD ... controlled with topical prescription therapies.

Opens in a new tab or window Atopic dermatitis (also known as eczema ... which may include moisturizers, prescription medications, and strategies to eliminate triggers. To help manage your ...

"With the FDA’s approval of VTAMA cream in atopic dermatitis for adults and children as young as 2 years old, there is now a therapy that offers the potential for powerful skin clearance with no ...